![Page 1: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/1.jpg)
The Effect of Exparil(Injectable Liposomal Bupivicaine) on length of stay after outpatient Midline Fusion
Nitin Khanna MD, FAAOSMichael Krzyskowski PA-C
www.nkspine.com
![Page 2: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/2.jpg)
Introduction
� Overall - Progression of Lumbar spine fusion to more minimally invasive techniques
� Overall shift of spine surgery to the outpatient surgery
� No clear Best practice for outpatient Lumbar fusions
� Outpatient surgery and Bundled payments – increased focus on “true costs of procedure”
![Page 3: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/3.jpg)
History of Spine Surgery
� Long procedures with high complication rate- “Don’t let anyone operate on your spine”
� Advanced technology with goal to improve outcomes with shorten recovery periods – Hours instead of Days� How else to accelerate
return home?
![Page 4: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/4.jpg)
Anatomy
� Muscle innervated from lateral to medial
� Release of fascia and retraction from medial to lateral preserves muscle neurovascular supply
![Page 5: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/5.jpg)
Cortical trajectory – Pedicle screws
� The key to the midline approach is ability to gain pedicle fixation utilizing a cortical trajectory screws – Medial to lateral trajectory
Cortical Screw
Traditional Screw
![Page 6: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/6.jpg)
Review of Literature
Nitin Khanna, MD, Gurvinder Deol, MD, Gregory Poulter, MD, and Arvind Ahuja, MD presented SMISS 2015
Cortical Screw
Traditional Screw
Flexion
Extension
Lateral
Bending
Axial
Rotation
Stif
fnes
s (%
of
inta
ct s
tiff
nes
s)
(Intact spine)
809%
615%
381%
511%
203%
170%
![Page 7: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/7.jpg)
SPINE publication
![Page 8: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/8.jpg)
Outpatient Poster presentation
Presented ISASS 2017
Avg Length of stay 133 minutes
No 30 day readmissions
EBL 69.2 cc
No infections
![Page 9: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/9.jpg)
Methods
� Retrospective review
� n= 30
� 14 Local anesthetic only� Marcaine with epi only for incision and into muscle after fascial
closure
� 16 local plus exparel� Marcaine with epi for incision, and Exparil injected into muscle
after fascial closure at conclusion of procedure
� Commercial insurance and worker’s compensation
![Page 10: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/10.jpg)
Results
� Length of stay – avg 123 minutes without, 142 with
![Page 11: stay after outpatient Midline Fusion Liposomal Bupivicaine) …615 % 381 % 511 % 203 % 170 % SPINE publication Outpatient Poster presentation Presented ISASS 2017 Avg Length of stay](https://reader033.vdocument.in/reader033/viewer/2022050610/5fb0f603e5bf9a156a1c8126/html5/thumbnails/11.jpg)
Takeways
� Exparel – mechanism of action consistent with longetr acting pain relief – so length of stays under 3 hours are more likely associated with the marcaine effect
� Patient selection for outpatient spine fusion is the most important factor in achieving shorter length of stays
� Great teamwork from preop, intraop nursing and anesthesia as well as potop – key to success